semaglutide peak plasma Human pharmacokinetics of [ 3 H]-semaglutide and metabolites detected Clinical Pharmacokinetics of Oral Semaglutide:

: , , ,

Tirzepatide added a second receptor, GIP, and its trials reported roughly 2122% average weight loss over 72 weeks, making it more effective than semaglutide in head-to-head comparisons

Effects of GLP-1 receptor agonists on pregnancy rate and menstrual cyclicity in women with polycystic ovary syndrome: A systematic review and meta-analysis

M., & Colditz, G

Tirzepatide initiation was actually associated with a lower overall risk of joint pain, including lower back pain, hip pain, and knee pain

This is fascinating - the muscle preservation aspect of Retatrutide seems like a huge advancement over current GLP-1s